✦ LIBER ✦
P58 The use of a multi-analyte immunoassay panel (MAIP) to detect potential prognostic biomarkers associated with 2-month progression free survival rate in patients treated with Enzastaurin as 2nd and 3rd line therapy of NSCLC
✍ Scribed by A. Cleverly; G. Bepler; Y. Oh; H. Burris; R.S. Herbst; M. Lahn
- Book ID
- 118626154
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 52 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.